Nomura Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Sell |
15,000
-55,000
| -79% | -$7.25M | ﹤0.01% | 1142 |
|
|
2026
Q1 | $9.76M | Sell |
70,000
-32,100
| -31% | -$4.5M | 0.03% | 434 |
|
|
2025
Q4 | $12.5M | Hold |
102,100
| – | – | 0.02% | 451 |
|
|
2025
Q3 | $11.3M | Sell |
102,100
-1,900
| -2% | -$216K | 0.02% | 490 |
|
|
2025
Q2 | $11.5M | Sell |
104,000
-113,100
| -52% | -$12M | 0.02% | 367 |
|
|
2025
Q1 | $24.3M | Buy |
217,100
+187,100
| +624% | +$19.3M | 0.05% | 257 |
|
|
2024
Q4 | $2.77M | Hold |
30,000
| – | – | ﹤0.01% | 975 |
|
|
2024
Q3 | $2.52M | Sell |
30,000
-75,000
| -71% | -$5.72M | 0.01% | 870 |
|
|
2024
Q2 | $7.2M | Buy |
105,000
+75,000
| +250% | +$5.01M | 0.01% | 564 |
|
|
2024
Q1 | $2.2M | Hold |
30,000
| – | – | 0.01% | 872 |
|
|
2023
Q4 | $2.43M | Buy |
+30,000
| New | +$2.33M | 0.01% | 896 |
|
|
2023
Q2 | – | Sell |
-45,000
| Closed | -$3.73M | – | 1459 |
|
|
2023
Q1 | $3.73M | Buy |
+45,000
| New | +$3.73M | 0.01% | 646 |
|
|
2019
Q2 | – | Sell |
-500,000
| Closed | -$32.9M | – | 1181 |
|
|
2019
Q1 | $32.9M | Buy |
+500,000
| New | +$33.2M | 0.14% | 116 |
|
|
2018
Q3 | – | Sell |
-125,500
| Closed | -$8.89M | – | 1375 |
|
|
2018
Q2 | $8.89M | Sell |
125,500
-2,016,900
| -94% | -$142M | 0.03% | 395 |
|
|
2018
Q1 | $163M | Buy |
2,142,400
+1,942,400
| +971% | +$154M | 0.28% | 44 |
|
|
2017
Q4 | $14.6M | Sell |
200,000
-70,100
| -26% | -$5.32M | 0.03% | 368 |
|
|
2017
Q3 | $22M | Sell |
270,100
-35,000
| -11% | -$2.68M | 0.05% | 225 |
|
|
2017
Q2 | $21.4M | Sell |
305,100
-74,900
| -20% | -$4.98M | 0.05% | 198 |
|
|
2017
Q1 | $25.8M | Buy |
380,000
+85,000
| +29% | +$5.98M | 0.07% | 132 |
|
|
2016
Q4 | $21.5M | Buy |
295,000
+75,000
| +34% | +$5.57M | 0.05% | 210 |
|
|
2016
Q3 | $17.5M | Buy |
220,000
+30,000
| +16% | +$2.44M | 0.05% | 195 |
|
|
2016
Q2 | $15.9M | Buy |
190,000
+25,000
| +15% | +$2.22M | 0.05% | 202 |
|
|
2016
Q1 | $15.1M | Buy |
165,000
+135,000
| +450% | +$12.2M | 0.05% | 158 |
|
|
2015
Q4 | $3.04M | Hold |
30,000
| – | – | 0.01% | 520 |
|
|
2015
Q3 | $2.93M | Buy |
+30,000
| New | +$3.33M | 0.01% | 508 |
|
|
2015
Q1 | – | Sell |
-63,000
| Closed | -$5.98M | – | 1952 |
|
|
2014
Q4 | $5.98M | Sell |
63,000
-92,100
| -59% | -$9.53M | 0.02% | 527 |
|
|
2014
Q3 | $16.3M | Buy |
155,100
+68,500
| +79% | +$6.71M | 0.04% | 315 |
|
|
2014
Q2 | $7.16M | Sell |
86,600
-14,400
| -14% | -$1.12M | ﹤0.01% | 528 |
|
|
2014
Q1 | $7.23M | Buy |
+101,000
| New | +$7.92M | ﹤0.01% | 594 |
|
Other funds holding GILD
Nomura Holdings's GILD Position: Q2 2026 in Review
Nomura Holdings reduced its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, selling an estimated $961K and leaving 154,417 shares worth $19.5M. The position accounts for 0.02% of the portfolio, ranked #369.
Nomura Holdings first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $63.7M in Q2 2019. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nomura Holdings held 154,417 shares of Gilead Sciences worth $19.5M as of Q2 2026.
- Nomura Holdings sold 7,296 Gilead Sciences shares in Q2 2026, an estimated $961K.
- Gilead Sciences made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #369 holding.
- Nomura Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- Nomura Holdings's Gilead Sciences position peaked at $63.7M in Q2 2019.
- 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.